| The effect of obesity on lung function |
63 |
| The role of ultrasound lung artifacts in the diagnosis of respiratory diseases |
42 |
| The burden of community-acquired bacterial pneumonia in the era of antibiotic resistance |
19 |
| The concepts of asthma endotypes and phenotypes to guide current and novel treatment strategies |
12 |
| Therapeutic targets for inflammation-mediated airway remodeling in chronic lung disease |
11 |
| Cystic fibrosis respiratory microbiota: unraveling complexity to inform clinical practice |
10 |
| Tezacaftor for the treatment of cystic fibrosis |
10 |
| Diagnosing and managing bronchiolitis obliterans in children |
9 |
| Epidemiology of lower respiratory tract infections in adults |
9 |
| Targeting transpulmonary pressure to prevent ventilator-induced lung injury |
9 |
| Cognitive impairment in chronic obstructive pulmonary disease: disease burden, determinants and possible future interventions |
9 |
| Recognizing, quantifying and managing patient-ventilator asynchrony in invasive and noninvasive ventilation |
9 |
| Diagnosis and management of central sleep apnea syndrome |
8 |
| The use of bronchoscopy in critically ill patients: considerations and complications |
8 |
| Oximetry use in obstructive sleep apnea |
8 |
| Diagnosis and management of laryngotracheal stenosis |
8 |
| Mepolizumab for severe eosinophilic asthma: a real-world snapshot on clinical markers and timing of response |
8 |
| Respiratory muscle function and exercise limitation in patients with chronic obstructive pulmonary disease: a review |
8 |
| How close are we to definitively identifying the respiratory health effects of e-cigarettes? |
8 |
| Role of IL-17 in asthma pathogenesis and its implications for the clinic |
8 |
| The effect of e-cigarette aerosol emissions on respiratory health: a narrative review |
8 |
| Prediction in obstructive sleep apnoea: diagnosis, comorbidity risk, and treatment outcomes |
7 |
| Lung transplantation in idiopathic pulmonary fibrosis |
7 |
| Ventilator-induced lung injury during controlled ventilation in patients with acute respiratory distress syndrome: less is probably better |
7 |
| Durvalumab for the treatment of non-small cell lung cancer |
6 |
| Multifaceted activity of N-acetyl-l-cysteine in chronic obstructive pulmonary disease |
6 |
| Predicting disease progression in cystic fibrosis |
6 |
| CFTR dysfunction in cystic fibrosis and chronic obstructive pulmonary disease |
6 |
| The impact of smoking and the influence of other factors on lung cancer |
5 |
| The challenge of avoiding intubation in immunocompromised patients with acute respiratory failure |
5 |
| Pulmonary fibrosis: a disease of alveolar collapse and collagen deposition |
5 |
| New options for combination therapy for advanced non-squamous NSCLC |
5 |
| Immunotherapy strategies for mesothelioma - the role of tumor specific neoantigens in a new era of precision medicine |
5 |
| Endemic pulmonary fungal diseases in immunocompetent patients: an emphasis on thoracic imaging |
5 |
| Obstructive sleep apnoea and comorbidity - an overview of the association and impact of continuous positive airway pressure therapy |
5 |
| Targeting airway inflammation in cystic fibrosis |
5 |
| Innovations in asthma therapy: is there a role for inhaled statins? |
5 |
| Treatment response heterogeneity in asthma: the role of genetic variation |
5 |
| Adherence and outcomes: a systematic review of palivizumab utilization |
5 |
| Existing and emerging biomarkers for disease progression in idiopathic pulmonary fibrosis |
5 |
| Predictors of tuberculosis treatment success under the DOTS program in Namibia |
5 |
| Pre-diagnostic body mass index trajectory in relationship to lung cancer incidence and mortality; findings from the PLCO trial |
4 |
| Safe and effective exercise training for patients with pulmonary arterial hypertension: putting current evidence into clinical practice |
4 |
| New concepts in the pathogenesis of sarcoidosis |
4 |
| Inhalation therapy for repairing damaged elastin fibers and decelerating elastinolysis in chronic obstructive pulmonary disease |
4 |
| Existing and emerging treatments for idiopathic pulmonary fibrosis |
4 |
| Cardiac sarcoidosis - an expert review for the chest physician |
4 |
| Oxygen saturation measurements in telemonitoring of patients with COPD: a systematic review |
4 |
| The role of immune checkpoint inhibitors in advanced non-small cell lung cancer |
4 |
| Thirty-five alternatives to positive airway pressure therapy for obstructive sleep apnea: an overview of meta-analyses |
4 |
